human health care company
Issues related to R&D tax credit; FY2023 Consolidated Appropriations Act (H.R.2617). Issues related to pharmaceutical IP and supply chain. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Proposed Part B IPI Demonstration Project; Drug Pricing; CMS NCD for Alzheimer's Drugs; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.4479/S.2609, Facilitating Innovative Nuclear Diagnostics Act of 2021; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation. Regulatory and legislative health care issues, including: 340B program; TRICARE Pharmacy Program; FDA Guidance on Alzheimer's drug development; Pharmaceutical Supply Chain; Drug Pricing; PDUFA Reauthorization; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022.
TAX - Taxation/Internal Revenue Code TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
BRITTANY JOHNSON HERNANDEZ JASON BENJAMIN VAN PELT MATHEW LAPINSKI BRITTANY JOHNSON HERNANDEZ JASON BENJAMIN VAN PELT MATHEW LAPINSKI BRITTANY JOHNSON HERNANDEZ JASON BENJAMIN VAN PELT MATHEW LAPINSKI BRITTANY JOHNSON HERNANDEZ JASON BENJAMIN VAN PELT MATHEW LAPINSKI